Yan Ming
Reporting owner on Forms 3, 4 and 5, CIK 1874041.
Yan Ming reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.CIK 1831915 | director, officer (CHIEF TECHNOLOGY OFFICER) | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +7,363 | 4,829,233 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -1,793 | $5.92 | 4,827,440 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +5,525 | 4,832,965 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -1,346 | $5.92 | 4,831,619 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +6,162 | 4,837,781 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -1,501 | $5.92 | 4,836,280 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +14,220 | 4,850,500 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | F withheld for tax | -3,463 | $5.92 | 4,847,037 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -7,363 | $0 | 9,826 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -5,525 | $0 | 29,470 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -6,162 | $0 | 57,526 | Form 4 |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -14,220 | $0 | 189,615 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001874041-26-000010 | Cytek Biosciences, Inc. | 2026-11-20 |